Contents
Contents
Laboratory travel allowance fraud bills Medicare for specimen-collection travel the technician did not make, inflates the miles, or misrepresents how a trip was shared among patients. The specimen can reach the laboratory while the travel claim tells a different story. A phlebotomist knows where the collection happened. A dispatcher knows who went there. A healthcare biller sees the miles charged to Medicare. Connecting those accounts can expose health care fraud: a claim for work that taxpayers never received.
A laboratory specimen collection fee and separately billed travel mileage pay for different parts of getting a sample to the laboratory. They also sit apart from payment for the test itself. The collection fee concerns the technician’s work drawing the specimen. The travel allowance covers eligible transportation and personnel expenses for reaching the patient to collect it.
The Centers for Medicare & Medicaid Services guidance for 2026 ties payment to a trained technician personally collecting a qualifying specimen for a clinical diagnostic laboratory test paid under the Clinical Laboratory Fee Schedule. The patient must be homebound or a non-hospital inpatient whose facility has no qualified personnel available to collect it. The qualifying collections are blood drawn by venipuncture and urine collected by catheterization.
That personal collection is the hinge. Medicare does not pay a travel allowance when a technician acts only as a messenger, picking up specimens somebody else drew. The test order, the draw and the transportation each describe a different part of the service. Billing them requires knowing who actually did the collection. Medicare also limits collection fees by patient encounter, so drawing additional specimens does not create a separate fee for each tube.
The guidance identifies collection codes 36415 for venipuncture, G0471 for blood or catheterized urine collected from a patient in a skilled nursing facility or by a laboratory on behalf of a home health agency, and P9612 and P9615 for catheterization. A travel claim depends on a payable collection service, which makes the collection entry part of the mileage inquiry.
Under the 2026 guidance, the flat-rate allowance applies to travel of 20 eligible miles or less to and from one collection location. The per-mile allowance applies when that round trip exceeds the threshold or when the technician visits more than one location, regardless of distance. The billing codes are P9604 for the flat rate and P9603 for the per-mile allowance.
The Centers for Medicare & Medicaid Services updates the mileage rate annually. For a billing review, the service date determines which year’s payment terms belong beside the claim.
When a mobile laboratory bills technician miles traveled by overnight courier, it substitutes the specimen’s journey for the technician’s. If the courier alone made that leg, those miles cannot become travel the technician made to collect the sample. The agency limits eligible mileage to the technician’s specimen-collection travel, and excludes messenger-only pickups.
Laboratory logistics make the distinction worth examining. Collection staff can work inside a physician’s office while a laboratory courier carries the specimen away. Large laboratory networks also use aircraft. The person drawing the blood and the service moving the tube can be different participants in the same operation.
For a claim involving an overnight shipment, we would put the technician’s schedule beside the collection record and courier or air waybill. The laboratory’s accession and receipt times can then help connect the sample to the shipment. The question is where the technician went and which part of that journey appeared on the Medicare claim.
The agency’s definition follows that person from the laboratory or another starting point to the collection locations and back to the laboratory or another ending point. It excludes personal travel, travel to collect from non-Medicare patients and miles to a location where no specimen was collected. A route can contain miles that never belong in the allowance. A shipment reaching the laboratory does not supply the missing technician trip.
Lab travel allowance apportionment for multiple patients on the same trip divides the eligible travel payment among the patients for whom Medicare pays a specimen collection fee. Under the 2026 guidance, non-Medicare patients are excluded from every part of that calculation.
For per-mile claims, Medicare multiplies eligible miles by the year’s mileage rate, then divides that amount by the number of patients for whom it pays the collection fee. The flat-rate allowance is also divided among qualifying patients. Billing the whole shared trip to each patient would charge Medicare repeatedly for the same travel.
The patient count therefore belongs beside the mileage. A list of tubes, draws or pickups can describe the work without identifying how many people the trip served. An insider who knows the nursing facility’s collection round may recognize the missing patients immediately.
The Department of Health and Human Services Office of Inspector General’s audit of Professional Clinical Laboratory examined ProLab’s claims paid in 2014 and 2015. Its allocation rule included both Medicare and non-Medicare patients from whom specimens were drawn or picked up on the trip. That historical calculation differs from the Medicare-only calculation in the 2026 guidance.
The audit also records the Centers for Medicare & Medicaid Services clarifying that the divisor should be patients, rather than specimens. ProLab’s documentation counted blood draws, urine pickups and microbiology pickups without specifying the number of patients.
The auditors gave a concrete example: five blood draws, seven urine pickups and two microbiology pickups. They used seven patients as the smallest possible count, although the work could have involved as many as 14 patients.
The distinction matters inside the billing system. A specimen count cannot tell the reviewer whether the same patient supplied several samples. We connect the people, the collection work and the route before comparing the claim with the payment rule for its year.
The ProLab audit found that 65 of 100 sampled travel-allowance claim lines failed Medicare requirements. The auditors estimated at least $319,277 in improper travel-allowance payments. The mileage was only part of the problem: patient counts and collection records also failed to support the bills.
ProLab’s phlebotomists generally followed standard routes from their homes to nursing facilities. Others worked on call, making an urgent draw and taking it directly to the laboratory. That operating difference matters when reconstructing the trip behind a claim: a routine collection round and an urgent dispatch need their own records.
The auditors found claims for more allocated miles than the mileage logs supported. ProLab officials attributed some discrepancies to a data entry clerk misreading or incorrectly adding miles, draws or both. The auditors also found mileage carried over from a later trip, even though the trip being billed should have ended when its specimens were dropped off at the laboratory.
For other claims, ProLab supplied printed Google maps instead of mileage logs, without enough information to establish patient or specimen counts. A map could show the route’s distance. It could not supply the missing collection history.
The fee schedule caused another problem. ProLab officials told the auditors they had not resubmitted claims paid at the previous year’s rate after new rates were released. The audit described both overpayments and underpayments from that issue. It gives an insider something specific to recognize: the trip may be entered correctly while the billing system still uses the wrong year’s rate.
The useful evidence connects the technician’s work with the claim and the decision that produced it. We examine how dispatch instructions, collection records, mileage logs, patient rosters, specimen handoffs and billing entries fit together. A route that looks plausible on a map can still be billed under the wrong patient count or include somebody else’s transportation.
For a phlebotomist, the starting knowledge may be the actual sequence of visits. For a dispatcher, it may be a route reassignment or courier handoff. For someone in billing, it may be an instruction to enter mileage that the technician’s log never showed. Those are different ways into the same question: how did this trip become this charge?
The Centers for Medicare & Medicaid Services permits electronic mileage documentation that can be shared with the Medicare contractor. A digital route record belongs beside the patient and collection records, because each answers a different part of the payment question. We also examine who selected the mileage, which allocation method the system used and how managers responded when employees challenged a discrepancy.
Model Plan Helps Laboratories Fight Fraud, published in Laboratory Medicine in 1997, described the Inspector General’s voluntary model plan, including audits, record retention and correction of systemic problems. We examine those policies and audit responses to understand what the laboratory did when employees questioned its mileage billing.
The travel cases put different failures in view: overstated car mileage, a court finding that billed mileage did not match the technician’s travel, and claims for collection procedures never performed. Each points back to the work behind the bill.
In a 1997 settlement, Laboratory Corporation of America paid $700,000 to resolve allegations of overstated phlebotomist mileage. The allegations concerned visits in personal vehicles to homebound and nursing home patients through Florida facilities formerly owned by its subsidiary National Health Laboratories.
A court found in 2018 that BestCare Laboratory Services knowingly submitted false Medicare travel claims at its owner’s direction. The claimed allowances did not reflect the miles technicians actually traveled to collect specimens from Texas nursing home residents.
In its August 2023 announcement, the Justice Department said BestCare and its owner agreed to pay an additional $5.7 million to resolve the outstanding judgment. The case began with a whistleblower, and the government joined it. The department said the whistleblower would receive $1.3 million from this settlement.
The PhlebXpress owners pleaded guilty to conspiring to commit health care fraud, according to the Justice Department’s January 2023 guilty-plea announcement. The announcement’s account of court documents in the criminal case says they agreed to overstate mileage and bill for services Medicare did not reimburse. One example from that criminal case puts the discrepancy in plain view: a second company, Phlebotomy Solutions, billed Medicare for 124.6 miles when the phlebotomist actually traveled 1.4 miles.
According to those criminal-case court documents, the owners used Phlebotomy Solutions to get around Medicare’s payment suspension of PhlebXpress. The services were still being provided by PhlebXpress employees and contractors from its offices. The business name on the claim had changed while the people doing the work had not. For someone inside the operation, the billing company’s name and the technician’s actual employer could tell different stories about the same visit.
The October 2024 Veni-Express civil settlement required the company and its owners to pay at least $135,000. The government alleged that Veni-Express billed for blood draws it did not perform during homebound patient visits and for associated mileage Medicare did not reimburse. The settlement also addressed alleged kickbacks to a marketer.
The whistleblowers included a former phlebotomist for another California provider and a technical director at a Texas laboratory.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In a laboratory travel qui tam case, the starting point may be knowledge of how the collection service actually ran and why its claims said something else. We work with you to connect that knowledge to the government’s payments and the people who directed the billing.
If you know the route, the collection work or the instructions behind inflated mileage, speak with our whistleblower experts about the travel claims. We build your strongest laboratory travel whistleblower case with you around the service Medicare paid for and the work the technician actually did. We bring in laboratory fraud whistleblower lawyers who understand collection and travel billing, and stay beside you throughout the case.